Compare GABC & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GABC | OMCL |
|---|---|---|
| Founded | 1910 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 1995 | 2000 |
| Metric | GABC | OMCL |
|---|---|---|
| Price | $44.39 | $43.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $47.67 | ★ $55.83 |
| AVG Volume (30 Days) | 88.8K | ★ 409.4K |
| Earning Date | 04-27-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | ★ 8.13 | N/A |
| EPS | ★ 0.88 | 0.25 |
| Revenue | $487,401,000.00 | ★ $787,309,000.00 |
| Revenue This Year | $16.78 | $6.77 |
| Revenue Next Year | $3.98 | $5.22 |
| P/E Ratio | ★ $49.67 | $174.40 |
| Revenue Growth | ★ 37.80 | 9.93 |
| 52 Week Low | $36.65 | $26.85 |
| 52 Week High | $45.00 | $51.84 |
| Indicator | GABC | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 53.20 |
| Support Level | $42.06 | $42.50 |
| Resistance Level | $44.59 | $45.06 |
| Average True Range (ATR) | 0.83 | 1.51 |
| MACD | 0.09 | -0.34 |
| Stochastic Oscillator | 92.88 | 58.69 |
German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.